TechCrunch: M&A

AUGUST 22, 2023

The company has manufactured hardware for programs including Boeing’s Starliner reusable spacecraft, Sierra Space’s Dream Chaser spaceplane and Airbus OneWeb’s satellite constellation. million in additional capital. Since that time, Sidus has raised at least $5.2

Mergers and Acquisitions 246

Mergers and Acquisitions Initial Public Offering Acquisitions Manufacturing 246

Francine Way

JULY 8, 2017

PE funds typically have 4-to-7-years ownership windows for an investment and look for an exit at the end of that period through a sale or an IPO (initial public offering). Lack of financial resources to grow: Lack of capital to properly market, R&D, and/or acquire may drive shareholders elsewhere.

M&A 130

M&A Acquisitions Sale Investment 130

Growth Business

JULY 11, 2023

1) Venture Capital Getting backing from a VC firm is extremely difficult. For Woodland, it’s important to pitch for additional capital at the right time in the company’s development and to be realistic about the amount you’re asking for. For more information, contact the British Venture Capital Association at www.bvca.co.uk

Finance 75

Finance Finance Business Funds 75

Focus Investment Banking

FEBRUARY 25, 2024

I still recall the metric that was drilled into me back then: hit $50 million in revenue and a few back-to-back years of profitability and you, too, can go public. The benefits of going public are significant. Lastly, going public is a liquidity event for the founders and early investors, allowing them to cash in on their success.

Private Equity 52

Private Equity IPO Equities Public Trading 52

Cooley M&A

JANUARY 25, 2023

Will 2023 see a resurgence of traditional public M&A deals or will macro factors and the looming threat of regulatory review continue to push biotechnology companies down creative paths? It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 22, 2025

That said, some industry participants still looked to capitalize on anticipated vulnerabilities in their competitors pipelines with meaningful M&A bets such as Eli Lillys $2.3 billion acquisition of Catalent, a leader in contract manufacturing for cell and gene therapies, stands out as the largest healthcare deal of 2024.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64